Date published: 2026-2-14

1-800-457-3801

SCBT Portrait Logo
Seach Input

SPNS3 Activators

Forskolin is notable for its capacity to elevate cAMP levels by stimulating adenylyl cyclase, which in turn can enhance the activity of proteins like SPNS3 via cAMP-dependent pathways. Another compound, IBMX, operates by inhibiting phosphodiesterases, which leads to an accumulation of cAMP within the cell, again supporting the activity of SPNS3. Dibutyryl cAMP, a synthetic analog of cAMP, can permeate cell membranes and mimic the action of endogenous cAMP, thus activating the same pathways and potentially upregulating SPNS3. Additionally, ionophores such as A23187 and Ionomycin effectively increase intracellular calcium concentrations, a signal that can activate numerous calcium-dependent proteins and pathways interconnected with SPNS3 function.

Protein kinase C, a pivotal signaling molecule in cells, is activated by compounds like PMA. This activation can trigger a signaling cascade that may intersect with the pathways regulating SPNS3. Genistein, a tyrosine kinase inhibitor, can also modulate signaling networks, ultimately influencing the activity of SPNS3. LY294002 disrupts PI3K/AKT signaling, while U0126 and PD98059 target the MAPK/ERK pathway by inhibiting MEK enzymes. These inhibitors can create a shift in cellular signaling dynamics, potentially resulting in the modulation of SPNS3 activity. SB203580's inhibition of p38 MAPK can similarly influence the signaling environment to affect proteins like SPNS3. Sodium orthovanadate acts as an inhibitor of protein tyrosine phosphatases, leading to an altered phosphorylation state of cellular proteins which may include regulatory proteins that control SPNS3 activity.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

IBMX

28822-58-4sc-201188
sc-201188B
sc-201188A
200 mg
500 mg
1 g
$260.00
$350.00
$500.00
34
(1)

Non-specific inhibitor of phosphodiesterases, increases cAMP by preventing its breakdown, indirectly enhancing SPNS3.

Dibutyryl-cAMP

16980-89-5sc-201567
sc-201567A
sc-201567B
sc-201567C
20 mg
100 mg
500 mg
10 g
$47.00
$136.00
$492.00
$4552.00
74
(7)

Cell-permeable cAMP analog that can activate cAMP-dependent pathways, thereby indirectly promoting SPNS3 activity.

A23187

52665-69-7sc-3591
sc-3591B
sc-3591A
sc-3591C
1 mg
5 mg
10 mg
25 mg
$55.00
$131.00
$203.00
$317.00
23
(1)

Ionophore that increases intracellular calcium levels, potentially activating calcium-dependent pathways involving SPNS3.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

Activates protein kinase C, which can modulate signaling pathways that may upregulate SPNS3 activity.

Ionomycin

56092-82-1sc-3592
sc-3592A
1 mg
5 mg
$78.00
$270.00
80
(4)

Increases intracellular calcium, similarly to A23187, potentially enhancing SPNS3 activity via calcium signaling.

Genistein

446-72-0sc-3515
sc-3515A
sc-3515B
sc-3515C
sc-3515D
sc-3515E
sc-3515F
100 mg
500 mg
1 g
5 g
10 g
25 g
100 g
$45.00
$164.00
$200.00
$402.00
$575.00
$981.00
$2031.00
46
(1)

Tyrosine kinase inhibitor that can modulate signaling pathways, potentially resulting in upregulation of SPNS3.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

PI3K inhibitor that can affect downstream signaling, which may include pathways regulating SPNS3 activity.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

MEK inhibitor that can alter the MAPK/ERK pathway, possibly leading to changes in SPNS3 activity.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

p38 MAPK inhibitor that may influence pathways affecting SPNS3 activity.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

Another MEK inhibitor, similar to U0126, that can modulate the MAPK/ERK pathway, affecting SPNS3 activity.